{
    "clinical_study": {
        "@rank": "50153", 
        "arm_group": [
            {
                "arm_group_label": "Medtronic RestoreSensor Frequency Setting 1", 
                "arm_group_type": "Experimental", 
                "description": "Frequency Setting 1"
            }, 
            {
                "arm_group_label": "Medtronic RestoreSensor Frequency Setting 2", 
                "arm_group_type": "Experimental", 
                "description": "Frequency Setting 2"
            }, 
            {
                "arm_group_label": "Medtronic RestoreSensor Frequency Setting 3", 
                "arm_group_type": "Experimental", 
                "description": "Frequency Setting 3"
            }, 
            {
                "arm_group_label": "Medtronic RestoreSensor Frequency Setting 4", 
                "arm_group_type": "Sham Comparator", 
                "description": "Frequency Setting 4"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the role of frequency settings on spinal cord\n      stimulation in the management of Failed Back Surgery Syndrome (SCS Frequency Study)."
        }, 
        "brief_title": "Spinal Cord Stimulation Frequency Study", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Failed Back Surgery Syndrome", 
        "condition_browse": {
            "mesh_term": "Failed Back Surgery Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least 18 years old at the time of informed consent\n\n          -  Willing and able to provide a signed and dated informed consent\n\n          -  Capable of comprehending and consenting in English\n\n          -  Willing and able to comply with all study procedures, study visits, and be available\n             for the duration of the study\n\n          -  On a stable dose (no new, discontinued or changes in) of all prescribed pain\n             medications and willing/able to maintain or only decrease the dose of all prescribed\n             pain medications\n\n          -  Tried appropriate conventional medical management for their pain\n\n          -  Not indicated for additional surgical treatment in the opinion of the referring\n             physician or spinal surgeon\n\n          -  Undergone previous spinal surgery\n\n          -  Diagnosed with FBSS with appropriate pain score\n\n          -  Primary pain at appropriate spinal level\n\n        Exclusion Criteria:\n\n          -  Has an active implanted device, whether turned on or off\n\n          -  Displays current signs of a systemic infection\n\n          -  Pregnant or lactating, inadequate birth control, or the possibility of pregnancy\n             during the study\n\n          -  Has untreated major psychiatric comorbidity\n\n          -  Has serious drug-related behavioral issues\n\n          -  Has neurological abnormalities unrelated to Failed Back Surgery Syndrome\n\n          -  Diagnosed with Raynaud disease\n\n          -  Diagnosed with Fibromyalgia\n\n          -  Has any active malignancy or has been diagnosed with cancer and has not been in\n             remission for at least 1 year prior to screening\n\n          -  Has secondary gains which, in the opinion of the investigator, are likely to\n             interfere with the study\n\n          -  Participating or planning to participate in another clinical trial\n\n          -  Has characteristics/limits of household or close contacts involved in study (eg,\n             family member already a study participant where blind could be broken)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01750229", 
            "org_study_id": "1668"
        }, 
        "intervention": [
            {
                "arm_group_label": "Medtronic RestoreSensor Frequency Setting 1", 
                "description": "Frequency Setting 1", 
                "intervention_name": "Medtronic RestoreSensor Frequency Setting 1", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Medtronic RestoreSensor Frequency Setting 2", 
                "description": "Frequency Setting 2", 
                "intervention_name": "Medtronic RestoreSensor Frequency Setting 2", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Medtronic RestoreSensor Frequency Setting 3", 
                "description": "Frequency Setting 3", 
                "intervention_name": "Medtronic RestoreSensor Frequency Setting 3", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Medtronic RestoreSensor Frequency Setting 4", 
                "description": "Frequency Setting 4", 
                "intervention_name": "Medtronic RestoreSensor Frequency Setting 4", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 18, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "United Kingdom"
                }, 
                "name": "Guy's and St. Thomas' NHS Foundation Trust"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "4", 
        "official_title": "Randomized Controlled Double-blind Cross-over Trial Evaluating the Role of Frequencies on Spinal Cord Stimulation in the Management of Failed Back Surgery Syndrome (SCS Frequency Study)", 
        "overall_official": {
            "affiliation": "Guy's and St Thomas' NHS Foundation Trust", 
            "last_name": "Adnan Al-Kaisy, Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Suspended", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Visual Analog Pain Scale", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01750229"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "MedtronicNeuro", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "MedtronicNeuro", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014", 
        "why_stopped": "Enrollment was temporarily suspended to align study materials with field safety notice."
    }
}